Patent ID: 9650425
Date: 2017-05-16
CPC Classifications: A61K,C07K

Claim:
1. A fusion polypeptide, comprising at least two of the following polypeptides: (a) a polypeptide comprising an immunogenic fragment consisting of at least about 20 to about 50 contiguous amino acids that is at least 75% identical to an amino acid sequence of the same length from SEQ ID NO:13 or SEQ ID NO:47, (b) a polypeptide comprising an immunogenic fragment consisting of at least about 20 to about 50 contiguous amino acids that is at least 75% identical to an amino acid sequence of the same length from SEQ ID NO:20 or SEQ ID NO:39, (c) a polypeptide comprising an immunogenic fragment consisting of at least about 20 to about 50 contiguous amino acids that is at least 75% identical to an amino acid sequence of the same length from SEQ ID NO:17 or SEQ ID NO:55, (d) a polypeptide consisting of at least about 20 to about 50 contiguous amino acids from SEQ ID NO:13 or SEQ ID NO:47, (e) a polypeptide consisting of at least about 20 to about 50 contiguous amino acids from SEQ ID NO:20 or SEQ ID NO:39, (f) a polypeptide consisting of least about 20 to about 50 contiguous amino acids from SEQ ID NO:17 or SEQ ID NO:55, wherein the fusion polypeptide is capable of eliciting opsonic antibodies against group A Streptococcus (GAS).